Exchange-Traded Funds

PJP - Invesco Dynamic Pharmaceuticals ETF

Equity - Sector Equity

Product Details

The Invesco Dynamic Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex℠ Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

as of 09/30/2018 09/30/2018

Performance

  YTD 1Yr 3Yr 5Yr 10Yr Since Inception
Index History (%)
Dynamic Pharmaceutical Intellidex Index 15.64 13.88 6.42 12.74 18.09 14.96
S&P Composite 1500 Pharmaceuticals Index 13.25 14.25 11.04 12.42 13.13 9.55
Dynamic Pharmaceutical Intellidex Index 15.64 13.88 6.42 12.74 18.09 14.96
S&P Composite 1500 Pharmaceuticals Index 13.25 14.25 11.04 12.42 13.13 9.55
Fund History (%)
Fund NAV 15.09 13.18 5.88 12.12 17.37 14.28
After Tax Held 14.86 12.92 5.14 11.39 16.89 13.91
After Tax Sold 8.92 7.82 4.34 9.45 14.74 12.25
Fund Market Price 14.95 13.22 5.89 12.13 17.40 14.28
Fund NAV 15.09 13.18 5.88 12.12 17.37 14.28
After Tax Held 14.86 12.92 5.14 11.39 16.89 13.91
After Tax Sold 8.92 7.82 4.34 9.45 14.74 12.25
Fund Market Price 14.95 13.22 5.89 12.13 17.40 14.28

Market returns are based on the midpoint of the bid/ask spread at 4 p.m. ET and do not represent the returns an investor would receive if shares were traded at other times. Performance data quoted represents past performance, which is not a guarantee of future results. Investment returns and principal value will fluctuate, and shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than performance data quoted. After-tax returns reflect the highest federal income tax rate but exclude state and local taxes. Fund performance reflects applicable fee waivers, absent which, performance data quoted would have been lower. After Tax Held and After Tax Sold are based on NAV. Returns less than one year are cumulative.

as of 09/30/2018

Growth of $10,000

Data beginning 10 years prior to the ending date of 09/30/2018. Fund performance shown at NAV.

An investor cannot invest directly in an index. The results assume that no cash was added to or assets withdrawn from the Index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

as of 10/18/2018

Market Cap & Style Allocations

Large-Cap Value 24.37%
Large-Cap Blend 29.09%
Large-Cap Growth 2.78%
Mid-Cap Value 11.33%
Mid-Cap Blend 2.93%
Mid-Cap Growth 4.82%
Small-Cap Value -
Small-Cap Blend 2.44%
Small-Cap Growth 22.24%

as of 10/18/2018 Top Holdings | View All

Fund Holdings subject to change

Ticker Company % of Fund
LLY Eli Lilly & Co 5.67
PFE Pfizer Inc 5.59
MRK Merck & Co Inc 5.56
JNJ Johnson & Johnson 5.45
ABT Abbott Laboratories 5.36
AMGN Amgen Inc 5.34
ABBV AbbVie Inc 4.90
BMY Bristol-Myers Squibb Co 4.87
INVA Innoviva Inc 3.06
PCRX Pacira Pharmaceuticals Inc/DE 3.02

Distributions | View All | Distribution Information

Ex-Date Record Date Pay Date $/
Share
Ordinary Income Short Term Gains Long Term Gains Return of Capital
09/24/2018 09/25/2018 09/28/2018 0.15923 0.15923 - - -
06/18/2018 06/19/2018 06/29/2018 0.11537 0.11537 - - -
03/19/2018 03/20/2018 03/29/2018 0.05634 0.05634 - - -
12/18/2017 12/19/2017 12/29/2017 0.10096 0.10096 - - -
09/18/2017 09/19/2017 09/29/2017 0.12281 0.12281 - - -
06/16/2017 06/20/2017 06/30/2017 0.15586 0.15586 - - -
03/17/2017 03/21/2017 03/31/2017 0.03683 0.03683 - - -
12/16/2016 12/20/2016 12/30/2016 0.20736 0.20736 - - -
09/16/2016 09/20/2016 09/30/2016 0.10701 0.10701 - - -
06/17/2016 06/21/2016 06/30/2016 0.17945 0.17945 - - -
03/18/2016 03/22/2016 03/31/2016 0.01779 0.01779 - - -
12/24/2015 12/29/2015 12/31/2015 1.13178 - 1.13178 - -
12/18/2015 12/22/2015 12/31/2015 2.47021 0.15249 0.65801 1.65971 -
09/18/2015 09/22/2015 09/30/2015 0.08643 0.08643 - - -
06/19/2015 06/23/2015 06/30/2015 0.13767 0.13767 - - -
03/20/2015 03/24/2015 03/31/2015 0.01816 0.01816 - - -
12/24/2014 12/29/2014 12/31/2014 1.65068 - 1.30356 0.34712 -
12/19/2014 12/23/2014 12/31/2014 0.09096 - - - -
09/19/2014 09/23/2014 09/30/2014 0.08221 - - - -
06/20/2014 06/24/2014 06/30/2014 0.14492 - - - -
12/20/2013 12/24/2013 12/31/2013 0.06505 - - - -
09/20/2013 09/24/2013 09/30/2013 0.04182 - - - -
06/21/2013 06/25/2013 06/28/2013 0.11871 - - - -
03/15/2013 03/19/2013 03/28/2013 0.00998 - - - -
12/21/2012 12/26/2012 12/31/2012 0.37330 - - - -
09/21/2012 09/25/2012 09/28/2012 0.06264 - - - -
06/15/2012 06/19/2012 06/29/2012 0.09360 - - - -
03/16/2012 03/20/2012 03/30/2012 0.01812 - - - -
12/16/2011 12/20/2011 12/30/2011 0.06416 - - - -
09/16/2011 09/20/2011 09/30/2011 0.05507 - - - -
06/17/2011 06/21/2011 06/30/2011 0.06065 - - - -
12/17/2010 12/21/2010 12/31/2010 0.05506 - - - -
09/17/2010 09/21/2010 09/30/2010 0.03606 - - - -
06/18/2010 06/22/2010 06/30/2010 0.03539 - - - -
12/18/2009 12/22/2009 12/31/2009 0.12832 - - - -
09/18/2009 09/22/2009 09/30/2009 0.06608 - - - -
06/19/2009 06/23/2009 06/30/2009 0.06491 - - - -
12/19/2008 12/23/2008 12/31/2008 0.04207 - - - -
09/19/2008 09/23/2008 09/30/2008 0.02950 - - - -
06/20/2008 06/24/2008 06/30/2008 0.05289 - - - -
12/21/2007 12/26/2007 12/31/2007 0.02176 - - - -
09/21/2007 09/25/2007 09/28/2007 0.02089 - - - -
06/15/2007 06/19/2007 06/29/2007 0.02110 - - - -
03/16/2007 03/20/2007 03/30/2007 0.01580 - - - -
12/15/2006 12/19/2006 12/29/2006 0.05529 - - - -
06/16/2006 06/20/2006 06/30/2006 0.02365 - - - -
03/17/2006 03/21/2006 03/31/2006 0.01237 - - - -
12/16/2005 12/20/2005 12/30/2005 0.01581 - - - -
09/16/2005 09/20/2005 09/30/2005 0.01493 - - - -

Frequency Distribution of Discounts & Premiums

    Bid/Ask MidPoint Above NAV
Quarter
Ending
Days 0.00-
0.25%
0.26-
0.50%
0.51-
0.99%
1.00-
1.49%
1.50-
1.99%
≥2.00%
09/30/2018 63 26 0 0 0 0 0
06/30/2018 64 10 0 0 0 0 0
03/31/2018 61 22 0 0 0 0 0
12/31/2017 63 14 0 0 0 0 0
Year Ended 2017 251 55 0 0 0 0 0
    Bid/Ask Midpoint Below NAV
Quarter
Ending
Days 0.00-
0.25%
0.26-
0.50%
0.51-
0.99%
1.00-
1.49%
1.50-
1.99%
≥2.00%
09/30/2018 63 37 0 0 0 0 0
06/30/2018 64 54 0 0 0 0 0
03/31/2018 61 38 1 0 0 0 0
12/31/2017 63 49 0 0 0 0 0
Year Ended 2017 251 195 0 1 0 0 0

Fund Inception: 06/23/2005

Shareholders may pay more than net asset value when they buy Fund shares and receive less than net asset value when they sell those shares, because shares are bought and sold at current market prices. Performance data quoted represents past performance, which is not a guarantee of future results.


 Risk & Other Information

Typically, security classifications used in calculating allocation tables are as of the last trading day of the previous month.

There are risks involved with investing in ETFs, including possible loss of money. Shares are not actively managed and are subject to risks similar to those of stocks, including those regarding short selling and margin maintenance requirements. Ordinary brokerage commissions apply. The Fund's return may not match the return of the Underlying Index. The Fund is subject to certain other risks. Please see the current prospectus for more information regarding the risk associated with an investment in the Fund.

Investments focused in a particular industry, such as pharmaceuticals and biotechnology and genome, are subject to greater risk, and are more greatly impacted by market volatility, than more diversified investments.

Stocks of small and mid-sized companies tend to be more vulnerable to adverse developments, may be more volatile, and may be illiquid or restricted as to resale.

The Fund is non-diversified and may experience greater volatility than a more diversified investment. 

The S&P Composite 1500® Pharmaceuticals (S&P Pharmaceuticals) Index consists of all pharmaceuticals stocks included in the S&P Composite 1500® Index.

The Global Industry Classification Standard was developed by and is the exclusive property and a service mark of MSCI, Inc. and Standard & Poor's.

The IntellidexTM Indexes are trademarks of NYSE Euronext or its affiliates and are licensed for use by Invesco Capital Management LLC in connection with the Invesco Intellidex investment products. The products are not sponsored or endorsed by NYSE Arca, and NYSE Arca makes no warranty or representation as to the accuracy and/or completeness of the Indexes or results to be obtained by any person from use of the Indexes or the trading of the products.

Beta is a measure of risk representing how a security is expected to respond to general market movements. Smart Beta represents an alternative and selection index based methodology that seeks to outperform a benchmark or reduce portfolio risk, or both. Smart beta funds may underperform cap-weighted benchmarks and increase portfolio risk.

as of 10/19/2018
4:00 PM EST

PJP
Intraday Stats

  • Last Trade $69.01
  • Current IIV $69.05
  • Change -$0.69
  • % Change -0.99%
as of 10/19/2018
  • NAV at market close $69.05

as of 10/19/2018

Fund Yield

  • SEC 30 Day Yield 0.74%
  • Distribution Rate 0.92%
  • 12 Month Distribution Rate 0.63%
  • 30-Day SEC Unsubsidized Yield
    as of 10/18/2018
    0.73%
as of 10/19/2018

Prior Close

  • Closing Price $69.70
  • Bid/Ask Midpoint $69.05
  • Bid/Ask Prem/Disc -
  • Bid/Ask Prem/Disc -
as of 06/30/2018

Fund Characteristics

  • Price/Earnings Ratio1 13.00
  • Price/Book Ratio1 3.25
  • ROE2 0.48%
  • Avg Market Cap2 $68,971MM

1 Weighted Harmonic Average

2 Weighted Average

Fund Details

  • Fund Ticker PJP
  • CUSIP # 46137V662
  • ISIN US46137V6627
  • Intraday NAV PJPIV
  • Index Ticker DZRTR
  • Index Provider NYSE Arca
  • Management Fee 0.50%
  • Total Expense Ratio 0.57%
  • Marginable Yes
  • Short Selling Yes
  • Options No
  • Exchange NYSE Arca
  • Inception Date 06/23/2005
  • # of Holdings 30
    as of 10/18/2018
as of 10/19/2018

Quick Facts

  • Previous Close $69.70
  • Open $69.76
  • Today's High $70.22
  • Today's Low $69.01
  • Today's Volume 12,516
  • 39,089 30-Day Avg Trading
    Volume
  • 52 Week High $74.29
  • 52 Week Low $59.82
  • Shares Outstanding 7.90MM
  • Market Value $545.5MM